Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04685304 · ClinicalTrials.gov registry record · NA
Pharmacogenomics Applied to Chronic Pain Treatment in Primary Care
A NA study of Chronic Pain, sponsored by Medstar Health Research Institute.
- Active
- Registry status
- NA
- Development phase
- 315
- Enrollment target
- 1
- Study location
NCT04685304 is a NA study of Chronic Pain that is active but no longer recruiting, run by Medstar Health Research Institute. The registered enrollment target is 315 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04685304, a NA study of Chronic Pain, is active but no longer recruiting, sponsored by Medstar Health Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 315 participants
- Enrollment target
- 1
- Study location
Study Summary
Pharmacogenomics (PGx) Applied to Chronic pain Treatment in primary care (PGx-ACT) is an open-label, prospective, randomized trial. Participants prescribed a relevant opioid and meet additional eligibility criteria will be randomized into either a PGx-guided care (intervention) arm or standard care (control) arm. The investigators will test the hypothesis that patients with intermediate or poor CYP2D6 metabolism assigned to PGx-guided care arm will experience improved pain control at 3 months compared to patients in the standard care arm. Additionally, the study investigators will be evaluating non-pain related uses of PGx information in the chronic pain population.
Conditions Studied
Interventions
- GENETIC Pharmacogenetic Testing
- OTHER Pharmacist Consultation Note
- OTHER Delayed pharmacogenetic testing
Study Locations (1)
Maryland
- MedStar Good Samaritan Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2020-12-02 |
| Est. Completion | 2024-04-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04685304
The ClinicalTrials.gov registry entry for NCT04685304 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (59% lower). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Pharmacogenetic Testing is the first listed.
NCT04685304 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04685304 about?
NCT04685304 is a clinical study titled "Pharmacogenomics Applied to Chronic Pain Treatment in Primary Care". Pharmacogenomics (PGx) Applied to Chronic pain Treatment in primary care (PGx-ACT) is an open-label, prospective, randomized trial. Participants prescribed a relevant opioid and meet additional eligibility criteria will be randomized into either a PGx-guided care (intervention) arm or standard care ...
What is the current status of trial NCT04685304?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 315 participants. The study started on 2020-12-02. Estimated completion is 2024-04-11.
What conditions does trial NCT04685304 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT04685304?
The interventions under investigation include: Pharmacogenetic Testing (GENETIC), Pharmacist Consultation Note (OTHER), Delayed pharmacogenetic testing (OTHER).
Who is sponsoring clinical trial NCT04685304?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04685304 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.